Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna L Forrest

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantationMatthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Leukemia & Lymphoma|July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionKevin W Song, Peter N Mollee, Donna E Hogge, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantationMatthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Leukemia & Lymphoma|July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionKevin W Song, Peter N Mollee, Donna E Hogge, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Pageof 5